|
ANGEL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.23720000045591E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.54090000548513E-08 |
| Normal-vs-Stage2 |
2.971600E-01 |
| Normal-vs-Stage3 |
1.255700E-03 |
| Normal-vs-Stage4 |
2.17569999999556E-05 |
| Stage1-vs-Stage2 |
2.510200E-01 |
| Stage1-vs-Stage3 |
9.287400E-01 |
| Stage1-vs-Stage4 |
4.795200E-01 |
| Stage2-vs-Stage3 |
2.925200E-01 |
| Stage2-vs-Stage4 |
1.190970E-01 |
| Stage3-vs-Stage4 |
4.810800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17929999998712E-06 |
| Normal-vs-AfricanAmerican |
7.78559999999873E-05 |
| Normal-vs-Asian |
5.642600E-04 |
| Caucasian-vs-AfricanAmerican |
6.229600E-01 |
| Caucasian-vs-Asian |
4.903600E-01 |
| AfricanAmerican-vs-Asian |
6.238000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.42569999828891E-08 |
| Normal-vs-Female |
2.696500E-02 |
| Male-vs-Female |
8.867800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.32719999999831E-05 |
| Normal-vs-Extreme_Weight |
1.61181999999149E-05 |
| Normal-vs-Obese |
3.964600E-03 |
| Normal-vs-Extreme_Obese |
3.754300E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.763600E-01 |
| Normal_Weight-vs-Obese |
2.686000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.183600E-01 |
| Extreme_Weight-vs-Obese |
2.843800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.706000E-01 |
| Obese-vs-Extreme_Obese |
4.052400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.421200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.816500E-04 |
| Normal-vs-Age(61-80Yrs) |
7.68840000553439E-08 |
| Normal-vs-Age(81-100Yrs) |
7.5091999995891E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.896600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.333380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.073500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.089700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.097970E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.992600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.20089999955786E-07 |
| Normal-VS-Type2 PRCC |
1.98370000004111E-06 |
| Normal-VS-KIRP CIMP |
7.426600E-01 |
| Normal-VS-Unclassified PRCC |
9.223500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.119600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.818200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.624200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.992000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.348950E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.656200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.61239999977248E-07 |
| Normal-vs-N1 |
9.917500E-03 |
| Normal-vs-N2 |
1.277950E-02 |
| N0-vs-N1 |
4.967600E-01 |
| N0-vs-N2 |
9.754400E-01 |
| N1-vs-N2 |
7.996600E-01 |
|
|
